Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02307253 · ClinicalTrials.gov registry record · NA
EUS GUIDED Transduodenal Biopsy Using the 19G Flex
A NA study of Abdominal Neoplasms, sponsored by Catholic University of the Sacred Heart.
- Completed
- Registry status
- NA
- Development phase
- 246
- Enrollment target
- 6
- Study locations
NCT02307253: Completed NA study of Abdominal Neoplasms, sponsored by Catholic University of the Sacred Heart.
NCT02307253 is a NA study of Abdominal Neoplasms that has completed, run by Catholic University of the Sacred Heart. The registered enrollment target is 246 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). The trial reports 6 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02307253, a NA study of Abdominal Neoplasms, has completed, sponsored by Catholic University of the Sacred Heart.
- COMPLETED
- Registry status
- NA
- Development phase
- 246 participants
- Enrollment target
- 6
- Study locations
Study Summary
This study evaluates the feasibility, safety and accuracy of a 19 gauge (19G) needle in nitinol in the performance of endoscopic ultrasound (EUS) guided transduodenal biopsy for the acquisition of samples for histologic analysis. Patients with lesions that can be approached only from the duodenum will be prospectively enrolled.
Primary Outcome
Number of patients in which it was possible to place the needle within the target lesion by a transduodenal route divided by the total number of enrolled patients.
Conditions Studied
Interventions
- DEVICE Expect™19Flex needle (Boston Scientific Corp.,Natick,MA,USA)
Study Locations (6)
Other
- Clinique du Trocadero - Paris
- AUSL Bologna Bellaria-Maggiore Hospital - Bologna
- ISMETT UPMC Italy - Palermo
- Digestive Endoscopy Unit, Universita' Cattolica del Sacro Cuore - Rome
Indiana
- Indiana Univerisity Health Medical Center - Indianapolis
Kanagawa
- Teikyo University Mizonokuchi Hospital, Departement of Gastroenterology - Kawasaki
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 246 participants |
| Start Date | 2013-06 |
| Est. Completion | 2015-10 |
| Phase | NA |
What the finished NCT02307253 record still lists
NCT02307253 is an interventional study that assigns participants to a tested intervention. The registered 246 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Abdominal Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which Expect™19Flex needle (Boston Scientific Corp.,Natick,MA,USA) is the first listed.
NCT02307253 lists 6 locations in 3 states (Other, Indiana, Kanagawa).
Frequently Asked Questions
What is clinical trial NCT02307253 about?
NCT02307253 is a clinical study titled "EUS GUIDED Transduodenal Biopsy Using the 19G Flex". This study evaluates the feasibility, safety and accuracy of a 19 gauge (19G) needle in nitinol in the performance of endoscopic ultrasound (EUS) guided transduodenal biopsy for the acquisition of samples for histologic analysis. Patients with lesions that can be approached only from the duodenum wi...
What is the current status of trial NCT02307253?
This trial is currently completed. It is a NA study. The enrollment target is 246 participants. The study started on 2013-06. Estimated completion is 2015-10.
What conditions does trial NCT02307253 study?
This clinical trial studies the following conditions: Abdominal Neoplasms.
What interventions are being tested in trial NCT02307253?
The interventions under investigation include: Expect™19Flex needle (Boston Scientific Corp.,Natick,MA,USA) (DEVICE).
Who is sponsoring clinical trial NCT02307253?
This trial is sponsored by Catholic University of the Sacred Heart, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02307253 being conducted?
This trial has 6 study locations across Indiana, Kanagawa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02307253's enrollment target sits among peer trials
246 436th of 2000 higher than 1,565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04973605 · 246 participants · Phase 1
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
- NCT06395168 · 246 participants · NA
Mayo Clinic Health System Northwest Wisconsin Integrated Maternal Postpartum Appointment Combination
- NCT07048769 · 246 participants · Phase 4
Paracervical Block for Pain Reduction in Saline Infusion Sonograms
- NCT07176650 · 246 participants · Phase 1
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia